Recent Trends in Nanocarrier-Based Targeted Chemotherapy: Selective Delivery of Anticancer Drugs for Effective Lung, Colon, Cervical, and Breast Cancer Treatment

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/jnm/volume-2020/9184284/figures/9184284.fig.001a.svgz" name="9184284.fig.001a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>Lipid-based nanocarriers</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/jnm/volume-2020/9184284/figures/9184284.fig.001b.svgz" name="9184284.fig.001b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Polymeric nanocarriers</td></tr><tr class="fig-image" id="c"><td><object data="https://static.hindawi.com/articles/jnm/volume-2020/9184284/figures/9184284.fig.001c.svgz" name="9184284.fig.001c" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(c) </b>Inorganic nanocarriers</td></tr></table>

<div>Different types of nanocarriers for drug delivery in cancer therapy.</div>

Journal of Nanomaterials

fig1

Figure 1

Figure 1: Recent Trends in Nanocarrier-Based Targeted Chemotherapy: Selective Delivery of Anticancer Drugs for Effective Lung, Colon, Cervical, and Breast Cancer Treatment 

Figure 1 | Recent Trends in Nanocarrier-Based Targeted Chemotherapy: Selective Delivery of Anticancer Drugs for Effective Lung, Colon, Cervical, and Breast Cancer Treatment 